Formerly Cardinal Health PTS, Newly Named Catalent Now Operates as Independent Company

Catalent Pharma Solutions, formerly Cardinal Health Pharmaceutical
Technologies and Services, today announced its official launch as an
independent operating company. The Blackstone Group acquired the
business from Cardinal Health in April 2007.

Catalent is a leading provider of advanced technologies, as well
as development, manufacturing and packaging solutions for
pharmaceutical, biotechnology and consumer healthcare companies in
nearly 100 countries. Catalent offers its customers nearly 75 years of
experience in providing advanced technologies and consistent product
supply across nearly every major dose form type, and holds more than
1,000 patents and patent applications.

Catalent has a long heritage of dose form innovation. Catalent
commercialized softgel capsule technology and Liqui-Gel(R)
formulations, created the "fast dissolve" oral tablet category with
Zydis(R), and introduced the vegetable-based capsule VegiCaps(R) Soft.
Catalent's proprietary drug delivery and packaging technologies and
expertise enable customers to achieve their desired clinical and
market outcomes, and are used in many well-known consumer health and
prescription drug products. Catalent is also known for its
child-resistant, senior-friendly and compliance-enhancing packaging
designs.

Customers will continue to rely on Catalent and its team of
specialized experts worldwide for its advanced technologies and
substantial expertise.

"Catalent intimately understands the global challenges our
customers face while developing and commercializing life-enhancing and
life-saving drugs or innovative consumer health products," said John
Lowry, president and CEO of Catalent Pharma Solutions. "By
consistently providing our customers with the technologies, services
and reliable solutions they have come to expect from us, we enable
them to focus on their own core competencies."

The Catalent name was created to combine the ideas embodied by the
words "catalyst" and "talent." Catalent serves as a catalyst for
success for its customers, enabling them to ensure product supply and
improve product effectiveness, while "talent" underscores the
company's breadth and depth of scientific, technical and local market
expertise around the world.

About Catalent

Headquartered in Somerset, New Jersey, Catalent is the leading
provider of advanced technologies, and development, manufacturing and
packaging services for pharmaceutical, biotechnology and consumer
healthcare companies in nearly 100 countries. The company applies its
local market expertise and technical creativity to advance treatments,
change markets and enhance patient outcomes. Catalent employs
approximately 10,000 at more than 30 facilities worldwide and
generates more than $1.7 billion in annual revenue. For more
information, visit www.catalent.com.